US & World News

Boiron action has been suspended from trading Monday at the opening of the Bourse de Paris at the request of laboratory specializing in homeopathy, and professionals do not exclude the announcement of a capital transaction can go up at delisting.

A spokesman for NYSE Euronext Paris announced that Boiron had requested the suspension pending the publication of a statement.

In Boiron, it was confirmed, without giving further details, a release would be issued shortly.

"An operation on capital does not really surprise me. It is even possible that the Boiron family, which controls, decides a delisting," said one analyst who requested anonymity."They do not communicate," he adds.

After the publication of its interim results and announcement of investments that have surprised analysts, the stock dropped from 7.59% last week and closed Friday at 25.35 euros.

At December 31, 2009, the family group Boiron held 49.75% and 57.47% of the capital of voting rights.

The Pierre Fabre group held 16.32% of capital, 29.65% were in the audience.

• The banks have passed the tests of soundness probably followed
• Renewed speculation about a market-based Alcatel-Lucent
• French car groups are struggling to convince the stock market
• Renault sold 3 billion euros of shares Volvo
• Syngenta optimistic for 2011 after a good first quarter

This entry was posted on Monday, September 6th, 2010 at 4:15 pm and is filed under advertising, blog, business opportunity, calculation, management. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.